Volgen
Richard Baker Jones
Richard Baker Jones
Independent biotechnology professional
Geverifieerd e-mailadres voor uchicago.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
15352021
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
A Halliday, M Harrison, E Hayter, X Kong, A Mansfield, J Marro, H Pan, ...
The Lancet 376 (9746), 1074-1084, 2010
10702010
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones, A Gordus, JA Krall, G MacBeath
Nature 439 (7073), 168-174, 2005
9212005
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
480*2021
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
C Yu, F Wang, M Kan, C Jin, RB Jones, M Weinstein, CX Deng, ...
Journal of Biological Chemistry 275 (20), 15482-15489, 2000
4282000
System and method for detecting fraudulent transactions
J Hillmer, R Jones, C Gessner, C Johnston, K Lewis, S Deshpande
US Patent App. 10/298,814, 2003
3742003
Innate immune and chemically triggered oxidative stress modifies translational fidelity
N Netzer, JM Goodenbour, A David, KA Dittmar, RB Jones, JR Schneider, ...
Nature 462 (7272), 522-526, 2009
3632009
Start-up, operation, monitoring and control of high-rate anaerobic treatment systems
RF Hickey, WM Wu, MC Veiga, R Jones
Water Science and Technology 24 (8), 207-255, 1991
3311991
System and method for detecting fraudulent transactions
JM Hillmer, RA Jones, CM Gessner, CS Johnston, KR Lewis Jr, ...
US Patent 6,714,918, 2004
3222004
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10274), 605, 2021
3162021
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study
WJ Sandborn, S Travis, L Moro, R Jones, T Gautille, R Bagin, M Huang, ...
Gastroenterology 143 (5), 1218-1226. e2, 2012
3072012
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
SPL Travis, S Danese, L Kupcinskas, O Alexeeva, G D'Haens, PR Gibson, ...
Gut 63 (3), 433-441, 2014
2942014
Fournier’s syndrome: necrotizing subcutaneous infection of the male genitalia
RB Jones, JV Hirschmann, GS Brown, JA Tremann
The Journal of urology 122 (3), 279-282, 1979
2841979
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
MF Ciaccio, JP Wagner, CP Chuu, DA Lauffenburger, RB Jones
Nature methods 7 (2), 148-155, 2010
2352010
A theoretical approach to the deformation of honeycomb based composite materials
FK Abd El-Sayed, R Jones, IW Burgess
Composites 10 (4), 209-214, 1979
2351979
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
2172022
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
SM Lee, I Khan, S Upadhyay, C Lewanski, S Falk, G Skailes, E Marshall, ...
The lancet oncology 13 (11), 1161-1170, 2012
2132012
Systematic discovery of TLR signaling components delineates viral-sensing circuits
N Chevrier, P Mertins, MN Artyomov, AK Shalek, M Iannacone, ...
Cell 147 (4), 853-867, 2011
2102011
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
J Wojcik, O Hantschel, F Grebien, I Kaupe, KL Bennett, J Barkinge, ...
Nature structural & molecular biology 17 (4), 519-527, 2010
1982010
Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs
S Ye, Y Luo, W Lu, RB Jones, RJ Linhardt, I Capila, T Toida, M Kan, ...
Biochemistry 40 (48), 14429-14439, 2001
1882001
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20